Polyskin: audience favorite Global Entrepreneurship Competition
Polyskin develops biomaterial-based innovative products for application in burn and wound healing. We use two biopolymers - Polylactic acid (PLA) and Polylactic-glycolic acid (PLGA), both USFDA approved biodegradable and biocompatible polymers that have been in use for the past 60 years, widely used as absorbable sutures in surgical procedures.
Pain Point we are addressing - Affordable solutions for burn wound management has been lacking in India and other developing countries. Existing solutions including tissue engineered skin, bio-active membranes, and grafting etc., are expensive and require specialized skills for administration, limiting their reach.
Our Solution is compelling - Polyskin has developed an innovative process, where biodegradable polymer particles encapsulated with drugs can be self-assembled into bio-membranes in a single step at room temperature and can be used immediately as artificial skin substitutes for burn and wound treatment.Inflatable Games
1. We prepare polylactide particles encapsulated with drugs at our facility and then distribute to hospitals where it can be stored without any special storage requirements.
2. When a burn case arrives, the particles can be immediately fused using our simple process at room temperature and the polymeric membrane of desired size and shape can be immediately transferred to the wound site.
3. This makes the process very easy to be done even in a small center and does not need any specialized equipment.
Thus Polyskin offers several benefits - easy to handle, reduces fluid loss and decreases the chances of infection, helps in faster clearance of infection and better regeneration of the skin, cheapest alternative for treatment of burn wounds, and increased availability of PLA leading to increased affordability.
Polyskin is a spin off company from National Institute of Immunology (NII), a premier biotech research center in India. The multidisciplinary team at Polyskin consists of a bioengineer, medical and pharmaceutical professionals.